EDCTP [to 21 January 2017]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
17 January 2017
Switzerland fully associated to Horizon 2020 per 1 January 2017
Switzerland became an Associated Country for the full Horizon 2020 programme
as of 1 January 2017. Consequently, Switzerland has regained the possibility to fully participate in the European & Developing Countries Clinical Trials Partnership. Swiss legal entities may participate and receive funding in EDCTP2 actions*. Switzerland may also become a full member of the EDCTP Association, the legal implementation structure for the second EDCTP programme….